Cargando…

Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients

A global effort is currently undertaken to restrain the COVID-19 pandemic. Host immunity has come out as a determinant for COVID-19 clinical outcomes, and several studies investigated the immune profiling of SARS-CoV-2 infected people to properly direct the clinical management of the disease. Thus,...

Descripción completa

Detalles Bibliográficos
Autores principales: Angioni, Roberta, Sánchez-Rodríguez, Ricardo, Munari, Fabio, Bertoldi, Nicole, Arcidiacono, Diletta, Cavinato, Silvia, Marturano, Davide, Zaramella, Alice, Realdon, Stefano, Cattelan, Annamaria, Viola, Antonella, Molon, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646225/
https://www.ncbi.nlm.nih.gov/pubmed/33159040
http://dx.doi.org/10.1038/s41419-020-03151-z
Descripción
Sumario:A global effort is currently undertaken to restrain the COVID-19 pandemic. Host immunity has come out as a determinant for COVID-19 clinical outcomes, and several studies investigated the immune profiling of SARS-CoV-2 infected people to properly direct the clinical management of the disease. Thus, lymphopenia, T-cell exhaustion, and the increased levels of inflammatory mediators have been described in COVID-19 patients, in particular in severe cases(1). Age represents a key factor in COVID-19 morbidity and mortality(2). Understanding age-associated immune signatures of patients are therefore important to identify preventive and therapeutic strategies. In this study, we investigated the immune profile of COVID-19 hospitalized patients identifying a distinctive age-dependent immune signature associated with disease severity. Indeed, defined circulating factors - CXCL8, IL-10, IL-15, IL-27, and TNF-α - positively correlate with older age, longer hospitalization, and a more severe form of the disease and may thus represent the leading signature in critical COVID-19 patients.